Today’s Market Winners and Losers
The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today's sole winner is a pharmaceutical company ...Read Full Story »
Posts related to ‘biopharmaceuticals’
Read Full Story »
Cell Therapeutics Collapses on Secondary Offering
Biopharmaceutical firm Cell Therapeutics Inc. (NASDAQ: CTIC) announced a secondary offering this morning of 60,000 shares of its Series 17 preferred stock at a price of $1,000.00 per share: Each ...Read Full Story »
Onyx Pharma Shares Halted Before FDA Approval
Shares of Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) were halted for about half an hour this morning pending an announcement from the company. Shares were up 5.2% when trading in the ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9965)
- Accounting (512)
- Active Trader (4413)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5083)
- Autos (1475)
- Banking & Finance (3794)
- Bankruptcy (282)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1997)
- Dividends & Buybacks (928)
- Earnings (4153)
- Economy (3704)
- Editor's Picks (516)
- ETFs & Mutual Funds (824)
- General (3837)
- Healthcare (1435)
- Housing (1041)
- Industrials (632)
- Infrastructure (605)
- International Markets (4178)
- Internet (2195)
- IPOs & Secondaries (1653)
- Jobs (158)
- Labor (657)
- Media (4204)
- Mergers & Acquisitions (2228)
- Oil & Gas (2578)
- Personal Finance (307)
- Politics (824)
- Polls (34)
- Regulation (1164)
- Retail (2586)
- Rumors (1093)
- Services (299)
- Special Report (376)
- Technology (3828)
- Telecom & Wireless (1693)
- Transportation (581)
- Value Investing (766)
